ArticleClinical and translational radiation oncology2022

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial.

Jakob Liermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.